HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2025)
HUTCHMED (China) (HCM) reported Non-Current Debt of $68.2 million for Q4 2025, up 0.51% quarter-over-quarter from $67.8 million in Q2 2025.
HUTCHMED (China) (HCM) Non-Current Debt (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Non-Current Debt data on file, last reported at $68.2 million in Q4 2025.
- Non-Current Debt for Q4 2025 came in at $68.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $68.2 million (changed N/A YoY), and the FY2025 annual result was $68.2 million, changed N/A from the prior year.
- Non-Current Debt grew to $68.2 million in Q4 2025 per HCM's latest filing, from $67.8 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $68.2 million in Q4 2025 and troughed at $18.1 million in Q4 2022.
- A 5-year average of $46.1 million and a median of $47.9 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt soared 38.57% in 2024, then grew 21.95% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $26.9 million in 2021, then sank by 32.63% to $18.1 million in 2022, then jumped by 121.76% to $40.1 million in 2023, then soared by 38.57% to $55.6 million in 2024, then gained by 22.57% to $68.2 million in 2025.
- Business Quant data shows HCM's Non-Current Debt at $68.2 million in Q4 2025, $67.8 million in Q2 2025, and $55.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | 68.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68.19 Mn |
| Dec 31, 2025 | 68.19 Mn |
| Jun 30, 2025 | 67.84 Mn |
| Jun 30, 2025 | 67.84 Mn |
| Jun 30, 2024 | 55.63 Mn |
| Jun 30, 2024 | 55.63 Mn |
| Jun 30, 2023 | 40.15 Mn |
| Jun 30, 2023 | 40.15 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Mar 31, 2021 | 26.87 Mn |
| Mar 31, 2021 | 26.87 Mn |
| Jun 30, 2020 | 26.84 Mn |
| Jun 30, 2020 | 26.84 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 26.74 Mn |
| Dec 31, 2018 | 26.74 Mn |
| Jun 30, 2018 | 26.69 Mn |
| Jun 30, 2018 | 26.69 Mn |